论文部分内容阅读
氨力农(amrinon,简称AR)是近年来问世的非洋地黄、非儿茶酚胺类的强心药.属磷酸二酯酶抑制剂,兼具强心和扩血管作用.我科自1995～1997年选择45例先天性心脏病伴重度肺动脉高压(PH)病儿术后应用AR取得了良好的临床疗效,报告如下.1,临床资料
Amrinon (AR) is a cardiotonic drug of non-digitalis and non-catecholamines that came out in recent years.It is a phosphodiesterase inhibitor with both cardiac and vasodilator effects Select 45 cases of congenital heart disease with severe pulmonary hypertension (PH) in children with AR after surgery achieved good clinical efficacy, the report is as follows.1, Clinical data